We are continuously monitoring the safety profile of our products and collaborate closely with authorities to ensure patient safety, including adequate information on gastrointestinal side effects in the label. In a statement to The Hill for their article Ozempic, Mounjaro manufacturers sued over risk of stomach paralysis by Julia Shapero an Eli Lilly spokesperson claimed: patient safety is the companys top priority, noting that it actively [engages] in monitoring, evaluating and reporting safety information for all of its medicines. There is something important here that Ive seen misinformation floating around about for years
Frequently, employer plans incorporate GLP-1 medications for weight management
This route bypasses the first-pass liver metabolism that limits conventional oral peptide delivery, though the pharmacokinetics differ from subcutaneous injection
Semaglutide medications are still the most popular weight loss medication to prescribe with 82% reporting they actively prescribe Ozempic, 65% reporting they actively prescribe Wegovy, and 37% prescribing Rybelsus
[DOI] [PubMed] [Google Scholar] 27.Lin YL, Juan IM, Chen YL, Liang YC, Lin JK